SCHEMBL7673541

SCHEMBL7673541

O=C(O)CNS(=O)(=O)c1ccc(NC(=O)c2cccs2)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.69
MEN1 O00255 9/20 0.64
KMT2A Q03164 9/20 0.64
MAPT P10636 7/20 0.64
ALDH1A1 P00352 3/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
TDP1 Q9NUW8 2/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
TSHR P16473 1/20 0.61
TP53 P04637 1/20 0.60
PKM P14618 1/20 0.59
HTT P42858 2/20 0.56
POLB P06746 1/20 0.56
MAPK1 P28482 1/20 0.56
GFER P55789 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669733 0.83 LMNA (0.63) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL12793496 0.81 MEN1 (0.77) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL4834530 0.80 LMNA (0.74) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14027195 0.79 ALDH1A1 (0.73) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL7585622 0.78 MAPT (0.65) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL7671626 0.77 GRM4 (0.58) LMNAALDH1A1NPC1RAB9A
SCHEMBL7673748 0.77 ALDH1A1 (0.74) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL4829970 0.76 MMP1 (0.67) LMNAKMT2A
SCHEMBL7674591 0.76 LMNA (0.62) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14534186 0.76 MMP1 (0.71) LMNAMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed